Saturday 17 October 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024. In the quarter to June 2026, revenue grew 31.7%, EPS grew 21.2% and free cash flow fell 29.9%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

110.16 3.21 −2.83%

Follow CORT

Alert me

Market cap: $12.3B
P/E: 212×
Fwd P/E: 139×
Dividend yield: —
F-score: 4/9
Altman Z: 14.11
Beneish M: −2.76
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	83.11	37.02	89.58	167.21
P/S ratio Full definition →		11.61	4.75	5.47	11.03
P/FCF ratio Full definition →		52.69	25.49	35.04	85.69
P/Operating CF Full definition →		157.96	94.01	(251.00)	273.16
P/B ratio Full definition →		13.62	5.58	6.60	12.98
Price to Tangible BV Full definition →		13.62	5.58	6.60	12.98
EV/Sales Full definition →		11.06	4.28	5.05	10.68
EV/EBITDA Full definition →		145.12	78.33	0.00	2,382.98
EV/Operating CF Full definition →		50.12	22.94	32.27	80.85
EV/FCF Full definition →		50.20	22.97	32.35	82.95
Quick Ratio Full definition →		2.85	2.60	2.53	2.50
Current Ratio Full definition →		3.14	2.92	2.86	2.86
Net Debt/EBITDA Full definition →		(38.93)	2,739.77	6.90	(7.31)
Debt/Assets Full definition →		0.64%	0.60%	0.00%	0.00%
Debt/Equity Full definition →		0.01	0.01	0.00	0.00
Asset Turnover Full definition →		0.92	0.91	0.93	0.98
Operating CF/Net income Full definition →		2.81	1.61	0.54	0.80
Capex/Depreciation Full definition →		0.00	0.01	(0.34)	(2.93)
Research and Development Expense of Revenue Full definition →		33.16%	32.09%	40.18%	21.04%
Selling, General and Administrative Expense of Revenue Full definition →		59.71%	64.43%	88.15%	61.25%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		11.02%	10.27%	13.97%	11.48%
Graham Net Nets Full definition →		0.04	0.08	0.06	0.03
Graham Number Full definition →		11.72	11.49	7.86	8.85
Earnings Yield Full definition →		1.20%	2.70%	1.12%	0.60%
Free Cash Flow Yield Full definition →		1.90%	3.92%	2.85%	1.17%
Revenue per Share Full definition →		2.01	1.95	1.58	2.43
Operating CF per Share Full definition →		0.53	0.37	(0.16)	0.32
Capex per Share Full definition →		0.00	0.00	0.00	(0.02)
Free Cash Flow per Share Full definition →		0.53	0.37	(0.16)	0.29
Cash per Share Full definition →		4.07	3.58	3.24	2.92
Shareholders Equity per Share Full definition →		6.10	6.24	6.11	6.70
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		6.10	6.24	6.11	6.70
Free Cash Flow Full definition →		54.48	38.40	(16.97)	31.02
Working Capital Full definition →		368.87	319.38	276.85	285.87
Capital Expenditures Full definition →		0.00	(0.05)	(0.20)	(2.53)
Net Current Asset Value Full definition →		349.43	296.62	249.14	256.75
EV/EBIT Full definition →		125.05	72.71	0.00	1,384.77
Capex to Sales Full definition →		0.00	0.00	0.00	0.01
Price to Operating Income Full definition →		131.24	80.68	0.00	1,430.53
Other line items
Average Receivables Full definition →		64.67	56.88	50.45	70.74
Average Payables Full definition →		26.52	27.91	30.63	19.22
Average Inventory Full definition →		10.20	12.64	13.63	12.73
Average Assets Full definition →		803.93	838.60	830.67	845.21
Average Common Equity Full definition →		635.37	663.70	660.64	670.78

Show all line items

Columns are period end dates

Stockrow Weekly